Abstract:Since the 2015 to 2016 outbreak in America, Zika virus (ZIKV) infected almost 900,000 patients. This international public health emergency was mainly associated with a significant increase in the number of newborns with congenital microcephaly and abnormal neurologic development, known as congenital Zika syndrome (CZS). Furthermore, Guillain-Barré syndrome (GBS), a neuroimmune disorder of adults, has also been associated with ZIKV infection. Currently, the number of ZIKV-infected patients has decreased, and most of the cases recently reported present as a mild and self-limiting febrile illness. However, based on its natural history of a typical example of reemerging pathogen and the lack of specific therapeutic options against ZIKV infection, new outbreaks can occur worldwide, demanding the attention of researchers and government authorities. Here, we discuss the clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations. Several studies have confirmed the tropism of ZIKV for neural progenitor stem cells by demonstrating the presence of ZIKV in the central nervous system (CNS) during fetal development, eliciting a deleterious inflammatory response that compromises neurogenesis and brain formation. Of note, while the neuropathology of CZS can be due to a direct viral neuropathic effect, adults may develop neuroimmune manifestations such as GBS due to poorly understood mechanisms. Antiganglioside autoantibodies have been detected in multiple patients with ZIKV infection-associated GBS, suggesting a molecular mimicry. However, further additional immunopathological mechanisms remain to be uncovered, paving the way for new therapeutic strategies.

Molecular and cellular insights into Zika virus-related neuropathies

The mechanisms of Zika virus-induced neuropathogenesis

Zika Virus Neuropathogenesis-Research and Understanding

Host and viral mechanisms of congenital Zika syndrome

Zika Virus-Induced Microcephaly and Its Possible Molecular Mechanism

Neurological complications of Zika virus infection

The emergence of Zika virus and its new clinical syndromes

Zika Virus: An Emerging Global Health Threat

Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis

Gist of Zika Virus pathogenesis

Advances in Zika Virus–Host Cell Interaction: Current Knowledge and Future Perspectives

Modulation of immune responses in the central nervous system by Zika virus, West Nile virus, and dengue virus

Neuropathogenesis of Zika Virus Infection : Potential Roles of Antibody-Mediated Pathology

Zika virus: a public health perspective

Exploring Zika Virus Impact on Endothelial Permeability: Insights into Transcytosis Mechanisms and Vascular Leakage

Pathogenicity and Structural Basis of Zika Variants with Glycan Loop Deletions in the Envelope Protein

The clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations

Protection of ZIKV infection-induced neuropathy by abrogation of acute antiviral response in human neural progenitors

Zika Virus and the Metabolism of Neuronal Cells

Mechanisms of Zika astrocyte infection and neuronal toxicity

Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia.